Guangzhou Lupeng Pharmaceutical

PharmaceuticalsSeries AGuangzhou, China

Latest round

Series A

Last raised

Jun 2020

Total raised

$24M

Investors

4

About Guangzhou Lupeng Pharmaceutical

Based in Guangzhou, China and established in 2018, Guangzhou Lupeng Pharmaceutical operates as a pharmaceutical company which focuses on molecular science. The company's main business is self-developed innovative drug for the treatment of major diseases such as tumor, hepatitis B, autoimmunity, etc. The company's main product is LP-108 which is a selective BCL-2 (B-cell lymphoma-2) inhibitor.

Who invested in Guangzhou Lupeng Pharmaceutical

4 investors across 2 rounds

See all investors in Guangzhou Lupeng Pharmaceutical

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Jun 23, 2020

    Amount

    $24M

    Investors

    Locked

  2. Seed

    Jun 27, 2018

    Amount

    Undisclosed

    Investors

    Locked

Questions about Guangzhou Lupeng Pharmaceutical

Who invested in Guangzhou Lupeng Pharmaceutical?

Guangzhou Lupeng Pharmaceutical has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Guangzhou Lupeng Pharmaceutical raised?

Guangzhou Lupeng Pharmaceutical has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Guangzhou Lupeng Pharmaceutical last raise money?

Guangzhou Lupeng Pharmaceutical's most recent round on record is a Series A, in Jun 2020.

What does Guangzhou Lupeng Pharmaceutical do?

Based in Guangzhou, China and established in 2018, Guangzhou Lupeng Pharmaceutical operates as a pharmaceutical company which focuses on molecular science.

Where is Guangzhou Lupeng Pharmaceutical headquartered?

Guangzhou Lupeng Pharmaceutical is headquartered in Guangzhou, China.

Which VCs invest in companies like Guangzhou Lupeng Pharmaceutical?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Guangzhou Lupeng Pharmaceutical's stage. Their profiles are linked below.

Raising like Guangzhou Lupeng Pharmaceutical? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.